Statistics for EyePoint Pharmaceuticals (id:6622 EYPT)
Valuation metrics
Market cap
611.19M
Enterprise value
397.91M
Trailing P/E (ttm)
-4.92
Forward P/E
-3.16
PEG ratio
-3.16
Price/Sales (ttm)
13.37
Price/Book (mrq)
2.19
Enterprise Value/Revenue
8.70
Enterprise Value/EBITDA
-3.47
Overview
Shares outstanding
68.25M
Float
47.59M
Shares short
9.68M
% Held by insiders
0.01%
% Held by institutions
0.93%
Average volume (10 days)
845.23K
Average volume (90 days)
Price summary
52-Week low
5.87
52-Week high
30.99
52-Week change
31.28%
Beta
1.52
50-Day moving average
9.77
200-Day moving average
13.76
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
December 09th, 2020
Ex-dividend date
Last split factor
2:1
Last split date
December 09th, 2020
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-226.57%
Operating margin
-311.17%
Operational effectiveness
Return on assets
-31.39%
Return on equity
-74.68%
Income statement
Revenue (ttm)
0.90
Revenue per share (ttm)
0.90
Quarterly revenue growth (yoy)
Gross profit (ttm)
41.39M
EBITDA
-114,583,800.00
Net income to common (ttm)
-103,570,000.00
Diluted EPS (ttm)
-1.99
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
253.79M
Total cash per share (mrq)
3.72
Total debt (mrq)
23.11M
Total Debt/Equity (mrq)
10.56
Current ratio (mrq)
550.40%
Book value per share (mrq)
4.09
Cash flow
Cash flow statement
-113,486,000.00
Levered free cash flow (LFCF)
-59,128,500.00